Search
Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.
News
15 January 2024
On 3 November 2023, the Dutch Supreme Court upheld the decision of the Court of Appeal of The Hague in which life sciences company AstraZeneca (“AZ”) was held not to be...
Insights and Analysis
04 February 2022
In a decision published on 19 January 2022, the District Court of The Hague used its discretionary powers to order disclosure of license and settlement agreements by both the Standard...
News
19 January 2022
On 18 January 2022, the ratification of the Protocol to the Agreement on a Unified Patent Court on provisional application (PPA) by the Austrian Parliament was notified to the Council of...
Insights and Analysis
13 January 2022
On 28 December 2021, the Court of Appeal of The Hague overturned a decision of the District Court in which life sciences company AstraZeneca (“AZ”) was held liable towards...
Insights and Analysis
21 October 2020
On 14 October 2020, the District Court of The Hague delivered its decision in a case between Dutch health insurer Menzis and life sciences company AstraZeneca (“AZ”). In its...
News
10 September 2020
The drive towards the future of mobility and COVID-19 have made the fourth publication of Getting the Deal Through - Automotive a special edition. It not only explores the particularities...
News
13 November 2017
On 3 November 2017, the Dutch Supreme Court (Hoge Raad) handed down a landmark decision on the infringement of second medical use patents in the Merck Sharp & Dohme Corp....
Insights and Analysis
07 January 2016
A key aim of the Unified Patent Court (UPC) is to provide a more streamlined and consistent approach to patent litigation in the participating member states, by providing a single forum for ...
